Exemestane Blocks Mesothelioma Growth Through Downregulation of cAMP, pCREB and CD44 Implicating New Treatment Option in Patients Affected by This Disease

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-13-69
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2020English

Evaluation of Anxiety and Depression in Caregivers of Patients Affected by Alzheimer’s Disease

Advances in Alzheimer's Disease
2015English

Streamline Your Discovery With Our New, Convenient Building Blocks Sourcing Option.

Chemical and Engineering News
Chemical Engineering
2014English

Streamline Your Discovery With Our New, Convenient Building Blocks Sourcing Option.

Chemical and Engineering News
Chemical Engineering
2014English

NF2 Blocks Snail-Mediated P53 Suppression in Mesothelioma

Oncotarget
Oncology
2015English

Option Value Calculation Affected Components

Regional Formation and Development Studies
2014English

The Place of Interventional Blocks in the Treatment of Avascular Necrosis Developing in Patients With Addison's Disease

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Latest Treatment Option and Technology Advancement in Corneal and Ocular Surface Disease

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Laminin Α5 Chain Metastasis- And Angiogenesis-Inhibiting Peptide Blocks Fibroblast Growth Factor 2 Activity by Binding to the Heparan Sulfate Chains of CD44

Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy